Skip to content

Application of Video-Assisted Single-Lumen Endotracheal Tube Combined with Bronchial Blocker in Patients Undergoing Thoracoscopic Radical Esophagectomy: A Prospective Randomized Controlled Trial

Application of Video-Assisted Single-Lumen Endotracheal Tube Combined with Bronchial Blocker in Patients Undergoing Thoracoscopic Radical Esophagectomy: A Prospective Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106616
Enrollment
Unknown
Registered
2025-07-28
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

China bears the heaviest burden of esophageal cancer globally, with annual new cases and deaths accounting for over 50% of the world's total. Surgical operation is the core of radical treatment for esophageal cancer. Among them, video-assisted thoracoscopic surgery (VATS) has gradually replaced traditional open thoracic surgery and become the clinical first choice due to its advantages of less tra

Interventions

Control group:Single tracheal tube
Test group:Video-assisted single tracheal tube

Sponsors

The Second Affiliated Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. ASA physical status classification = III; 3. Scheduled for elective video-assisted thoracoscopic radical esophagectomy.

Exclusion criteria

Exclusion criteria: 1. With a history or anticipation of difficult tracheal intubation (body mass index > 35 kg/m², limited neck movement, mouth opening = 3); 2. Radiological evidence of lower airway anatomical abnormalities; 3. Previous thoracic surgery or ipsilateral pleurectomy; 4. Trauma patients or those with any conditions prohibiting the placement of bronchial blockers, a; 5. With a history of mental illness.

Design outcomes

Primary

MeasureTime frame
Duration of one-lung ventilation and operation time;Time to achieve one-lung ventilation;

Secondary

MeasureTime frame
Incidence of postoperative pneumonia;Number of occurrences and duration of intraoperative hypoxemia;Extubation time, recovery time;Number of uses and duration of flexible bronchoscope;ICU stay time, hospital stay time, hospitalization expenses;Incidence of hoarseness and sore throat immediately after extubation and 24 hours after surgery;Quality of lung collapse;Incidence of endotracheal tube displacement;Vital signs;Number of cases with correct initial placement of the blocker (success rate), number of attempts for correct placement of the blocker;Satisfaction of anesthesiologists and surgeons at the end of the operation;

Countries

China

Contacts

Public ContactMin Yan

The Second Affiliated Hospital of Zhejiang University School of Medicine

zryanmin@zju.edu.cn+86 571 87783716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026